Download the free
Parkinson's disease
case study
Sano worked with a pioneering biotech company to identify, screen and retain LRRK2:G2019S genetic Parkinson’s Disease (PD) patients for the initial stages of a new treatment development program.
Global prevalence rates of this genetic variation are 1% in sporadic PD and 4% in familial PD.
Download our case study to learn more.
![parkinsons case study cover parkinsons case study cover](https://sanogenetics.com/hs-fs/hubfs/parkinsons%20case%20study%20cover.png?width=300&height=421&name=parkinsons%20case%20study%20cover.png)
Download Case Study
Parkinson's disease Case Study
Sano worked with a pioneering biotech company to identify, screen and retain LRRK2:G2019S genetic Parkinson’s Disease (PD) patients for the initial stages of a new treatment development program.
Global prevalence rates of this genetic variation are 1% in sporadic PD and 4% in familial PD.
![parkinsons case study cover parkinsons case study cover](https://sanogenetics.com/hs-fs/hubfs/parkinsons%20case%20study%20cover.png?width=300&height=421&name=parkinsons%20case%20study%20cover.png)
Key Highlights
![Group 333-1 Group 333-1](https://sanogenetics.com/hs-fs/hubfs/Group%20333-1.png?width=286&height=113&name=Group%20333-1.png)
2x the industry benchmark hit-rate
![Group 334 Group 334](https://sanogenetics.com/hs-fs/hubfs/Group%20334.png?width=58&height=80&name=Group%20334.png)
55% cost savings using at-home DNA testing service vs. site visit